Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors Corrigendum in /ijmm/35/4/1147

Liu,Dehong; Shen,Liping; Tao,Yonglin; Kuang,Ying; Cai,Lei; Wang,Dan; He,Meiduo; Tong,Xuebo; Zhou,Shuguang; Sun,Jie; Shi,Chenchen; Wang,Chunxiao; Wu,Yi

doi:10.3892/ijmm.2014.2015

Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors

Corrigendum in: /ijmm/35/4/1147

Authors:
- Dehong Liu
- Liping Shen
- Yonglin Tao
- Ying Kuang
- Lei Cai
- Dan Wang
- Meiduo He
- Xuebo Tong
- Shuguang Zhou
- Jie Sun
- Chenchen Shi
- Chunxiao Wang
- Yi Wu
View Affiliations

Affiliations: Department of Pediatric Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China, Department of Pediatrics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China, Shanghai Research Center for Model Organisms, Shanghai 201203, P.R. China, School of Life Science, Shanghai University, Shanghai 200444, P.R. China
Published online on: November 28, 2014 https://doi.org/10.3892/ijmm.2014.2015
Pages: 399-404

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, we aimed to explore the effect of environmental endocrine disruptors (EEDs) on sexual differentiation in androgen receptor (AR)-/-, AR+/- and AR+/+ male mice. By using a Cre-loxP conditional knockout strategy, we generated AR knockout mice. By mating flox-AR female mice with AR-Cre male mice, the offspring male mice which were produced were examined. Mice not subjected to any type of intervention were used as the controls. Furthermore, male mice of different genotypes were selected and further divided into subgroups as follows: the control group, bisphenol A (BPA) group and the D binding protein (DBP) group. The expression of the Wilms tumor 1 (WT1), lutropin/choriogonadotropin receptor (LHR), 17-β-hydroxysteroid dehydrogenase type 3 (17βHSD3) and steroid-5-alpha-reductase, alpha polypeptide 2 (SRD5A2) genes was determined by RT-qPCR and western blot analysis. There was no statistically significant difference in the weight of the mice between the control group and the knockout group (P>0.05). The results revealed that, compared with the control group, in the knockout group, anogenital distance was shortened, and testicular weight and testosterone levels were decreased; estradiol levels were elevated; the differences were statistically significant (P<0.05). In the group of AR+/- male mice exposed to 100 mg/l EEDs, hypospadias was successfully induced, suggesting that EEDs are involved in the embryonic stage of sexual development in male mice. The quantitative detection of WT1, LHR, 17βHSD3 and SRD5A2 gene expression by RT-qPCR and western blot analysis indicated that these genes were significantly downregulated in the mice in the BPA group. In conclusion, exposure to EEDs induces hypospadias in heterozygous and wild-type male mice offspring during sexual differentiation, but has no effect on homozygous offspring. Therefore, EEDs play an important role during the third stage of sexual differentiation.

View Figures

View References

1	Yang J, Hauser R and Goldman RH: Taiwan food scandal: the illegal use of phthalates as a clouding agent and their contribution to maternal exposure. Food Chem Toxicol. 58:362–368. 2013. View Article : Google Scholar : PubMed/NCBI
2	Li X, Ye L, Wang X, et al: In silico investigations of anti-androgen activity of polychlorinated biphenyls. Chemosphere. 92:795–802. 2013. View Article : Google Scholar : PubMed/NCBI
3	Pan C, Wang Q, Liu YP, et al: Anti-androgen effects of the pyrethroid pesticide cypermethrin on interactions of androgen receptor with corepressors. Toxicology. 311:178–183. 2013. View Article : Google Scholar : PubMed/NCBI
4	Steketee K, Timmerman L, Ziel-van der Made AC, Doesburg P, Brinkmann AO and Trapman J: Broadened ligand responsiveness of androgen receptor mutants obtained by random amino acid substitution of H874 and mutation hot spot T877 in prostate cancer. Int J Cancer. 100:309–317. 2002. View Article : Google Scholar : PubMed/NCBI
5	Jenster G, van der Korput HA, Trapman J and Brinkmann AO: Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem. 270:7341–7346. 1995. View Article : Google Scholar : PubMed/NCBI
6	Li J and Al-Azzawi F: Mechanism of androgen receptor action. Maturitas. 63:142–148. 2009. View Article : Google Scholar : PubMed/NCBI
7	Bao AM and Swaab DF: Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuro-psychiatric disorders. Front Neuroendocrinol. 32:214–226. 2011. View Article : Google Scholar : PubMed/NCBI
8	Raznahan A, Lee Y, Stidd R, et al: Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proc Natl Acad Sci USA. 107:16988–16993. 2010. View Article : Google Scholar : PubMed/NCBI
9	Lazaros L, Xita N, Takenaka A, Sofikitis N, Makrydimas G, Stefos T, Kosmas I, Zikopoulos K, Hatzi E and Georgiou I: Semen quality is influenced by androgen receptor and aromatase gene synergism. Hum Reprod. 27:3385–3392. 2012. View Article : Google Scholar : PubMed/NCBI
10	Sarachana T, Xu M, Wu RC and Hu VW: Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism. PloS One. 6:e171162011. View Article : Google Scholar : PubMed/NCBI
11	Heinlein CA and Chang C: Androgen receptor (AR) coregulators: an overview. Endocr Rev. 23:175–200. 2002. View Article : Google Scholar : PubMed/NCBI
12	Wilhelm D and Koopman P: The makings of maleness: towards an integrated view of male sexual development. Nat Rev Genet. 7:620–631. 2006. View Article : Google Scholar : PubMed/NCBI
13	Hiort O and Holterhus PM: The molecular basis of male sexual differentiation. Eur J Endocrinol. 142:101–110. 2000. View Article : Google Scholar : PubMed/NCBI
14	Yeh S, Tsai MY, Xu Q, et al: Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA. 99:13498–13503. 2002. View Article : Google Scholar : PubMed/NCBI
15	Holt CL and May GS: A novel phage λ replacement Cre-lox vector that has automatic subcloning capabilities. Gene. 133:95–97. 1993. View Article : Google Scholar : PubMed/NCBI
16	Teixeira J, Kehas DJ, Antun R and Donahoe PK: Transcriptional regulation of the rat Müllerian inhibiting substance type II receptor in rodent Leydig cells. Proc Natl Acad Sci USA. 96:13831–13838. 1999. View Article : Google Scholar
17	Burnette WN: ‘Western blotting’: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 112:195–203. 1981. View Article : Google Scholar : PubMed/NCBI
18	Carmichael SL, Shaw GM, Nelson V, Selvin S, Torfs CP and Curry CJ: Hypospadias in California: trends and descriptive epidemiology. Epidemiology. 14:701–706. 2003. View Article : Google Scholar : PubMed/NCBI
19	Kalfa N, Philibert P and Sultan C: Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl. 32:187–197. 2009. View Article : Google Scholar
20	Rey RA and Grinspon RP: Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metab. 25:221–238. 2011. View Article : Google Scholar : PubMed/NCBI
21	Ching ST, Cunha GR, Baskin LS, Basson MA and Klein OD: Coordinated activity of Spry1 and Spry2 is required for normal development of the external genitalia. Dev Biol. 386:1–11. 2014. View Article : Google Scholar
22	Qiao L, Tasian GE, Zhang H, et al: Androgen receptor is overexpressed in boys with severe hypospadias, and ZEB1 regulates androgen receptor expression in human foreskin cells. Pediatr Res. 71:393–398. 2012. View Article : Google Scholar : PubMed/NCBI
23	Vottero A, Minari R, Viani I, et al: Evidence for epigenetic abnormalities of the androgen receptor gene in foreskin from children with hypospadias. J Clin Endocrinol Metab. 96:E1953–E1962. 2011. View Article : Google Scholar : PubMed/NCBI
24	Bhoj EJ, Ramos P, Baker LA, et al: Human balanced translocation and mouse gene inactivation implicate Basonuclin 2 in distal urethral development. Eur J Hum Genet. 19:540–546. 2011. View Article : Google Scholar : PubMed/NCBI
25	Miller JR: Some epidemiological aspects of teratogen detection. Mutat Res. 33:45–54. 1975. View Article : Google Scholar : PubMed/NCBI
26	Parker A, Newell KW, Torfs M and Israel E: Appropriate tools for health care: developing a technology for primary health care and rural development. WHO Chron. 31:131–137. 1977.PubMed/NCBI
27	Czeizel A, Toth J and Czvenits E: Increased birth prevalence of isolated hypospadias in Hungary. Acta Paediatr Hung. 27:329–337. 1985.
28	Matlai P and Beral V: Trends in congenital malformations of external genitalia. Lancet. 325:1081985. View Article : Google Scholar
29	Baskin LS, Himes K and Colborn T: Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect. 109:11752001. View Article : Google Scholar : PubMed/NCBI
30	Wang MH and Baskin LS: Endocrine: disruptors, genital development, and hypospadias. J Androl. 29:499–505. 2008. View Article : Google Scholar : PubMed/NCBI
31	Dalsenter P, Santana G, Grande S, Andrade AJ and Araujo S: Phthalate affect the reproductive function and sexual behavior of male Wistar rats. Hum Exp Toxicol. 25:297–303. 2006. View Article : Google Scholar : PubMed/NCBI
32	Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer GD and Ingraham HA: Wilms’ tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 93:445–454. 1998. View Article : Google Scholar : PubMed/NCBI
33	Hanley NA, Ball SG, Clement-Jones M, et al: Expression of steroidogenic factor 1 and Wilms’ tumour 1 during early human gonadal development and sex determination. Mech Dev. 87:175–180. 1999. View Article : Google Scholar : PubMed/NCBI
34	Wu SM, Leschek EW, Rennert OM and Chan WY: Luteinizing hormone receptor mutations in disorders of sexual development and cancer. Fetal Pediatr Pathol. 19:21–40. 2000. View Article : Google Scholar
35	Geissler WM, Davis DL, Wu L, et al: Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet. 7:34–39. 1994. View Article : Google Scholar : PubMed/NCBI
36	Rosler A: Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism. J Steroid Biochem Mol Biol. 43:989–1002. 1992. View Article : Google Scholar
37	Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P and Metter EJ: Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev. 14:2257–2260. 2005. View Article : Google Scholar : PubMed/NCBI
38	Schatzl G, Madersbacher S, Thurridl T, Waldmueller J, Kramer G, Haitel A and Marberger M: High-grade prostate cancer is associated with low serum testosterone levels. Prostate. 47:52–58. 2001. View Article : Google Scholar : PubMed/NCBI
39	Choi JH, Kim GH, Seo EJ, Kim KS, Kim SH and Yoo HW: Molecular analysis of the AR and SRD5A2 genes in patients with 46, XY disorders of sex development. J Pediatr Endocrinol Metab. 21:545–553. 2008.PubMed/NCBI